Marketing, profit drive demand for robotic surgeries: Aggressive marketing is driving exploding demand for robotic-assisted surgery for prostate cancer, even if new research shows that it isn’t any better than low-tech surgery.
And marketing, in turn, is driven by big bucks that makers and operators of the new laparoscopic robots can make, the New York Times suggests in a report.
One in six American men develop prostate cancer in their lifetime. Treatment options include radiation and watchful waiting, but the most popular is surgery.
Continue reading “Prostate Cancer Robotic Surgery Side Effects: Impotence & Incontinence?”